US.CAH · Cardinal Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.1154025614783407,
        "turnoverUsdM": 260.748023116,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CAH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 224.6458,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.2,
      "take_profit_price": 246.2985,
      "target_multiplier": 1.9,
      "technical_strength": 1.68,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.230805122956681,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 56.7,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 51.7,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 237.1665,
    "ma50": 234.2584,
    "close": 234.57,
    "prevClose": 236.02,
    "avgVolume20": 1445705,
    "volumeRatio": 0.77,
    "changePercent": -0.61
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": -0.05647395519086129,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 5,
      "vcp_bonus": 0,
      "vol_ratio": 0.7254075359897676,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.4363994540978642,
      "volat_points": 2,
      "day_range_pct": 0.029117021395872415,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 56.7,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 60,
        "contribution": 3
      },
      {
        "raw": 6.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 34,
        "contribution": 6.8
      },
      {
        "raw": 9.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 65.33,
        "contribution": 9.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 18.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 62.33,
        "contribution": 18.7
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 51.7,
    "details": [
      "基本面分析總分: 3/5分",
      "資金流分析總分: 6.8/20分",
      "市場環境分析總分: 9.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 18.7/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3,
      "資金流": 6.8,
      "市場環境": 9.8,
      "情緒分析": 4,
      "技術信號": 18.7,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.4,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 260.748023116,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CAH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 17.84
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 715.6679992,
                "ma50": 710.4063990999997,
                "name": "QQQ",
                "close": 714.88,
                "points": 1.4
              },
              "spy": {
                "ma20": 766.87899445,
                "ma50": 758.61640102,
                "name": "SPY",
                "close": 764.28998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.1154025614783407,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142089518,
                "url": "https://finnhub.io/api/news?id=2b34a2a5a93661fb44b03a5ae23beb9474b495656e1ceef30023166f3e89facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.",
                "category": "company",
                "datetime": 1789150860,
                "headline": "CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?"
              },
              {
                "id": 142062044,
                "url": "https://finnhub.io/api/news?id=560137700fdb0274b2b3959c029fe5878e28a09596be394126c5f9b6d5d4d425",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1789054203,
                "headline": "Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 142025489,
                "url": "https://finnhub.io/api/news?id=47bba7df8cd0884beabbaf391ec5402e0d0ff0dd0ffcf3aeb8b78535c839408c",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:45 AM EDTCompany ParticipantsDavid Frost - Vice President of...",
                "category": "company",
                "datetime": 1788951426,
                "headline": "Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141956423,
                "url": "https://finnhub.io/api/news?id=3f6f83c743ea38a72b4e2871141f4b5f6bc24bd2000d221a4a264cb9b5aaed21",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.",
                "category": "company",
                "datetime": 1788904802,
                "headline": "Cardinal Health (CAH) Declines More Than Market: Some Information for Investors"
              },
              {
                "id": 141406350,
                "url": "https://finnhub.io/api/news?id=7f06d643160898f1cbdc391a8a9105109c98cd0a5edf1bf978d1a4c97a7e8a62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]",
                "category": "company",
                "datetime": 1788472375,
                "headline": "Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”"
              },
              {
                "id": 141363638,
                "url": "https://finnhub.io/api/news?id=381f009c81a44d952d5b643ae88cfde27e54b5e058c2e9ad1f0d9b32734760d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In August 2026, Cardinal Health reported fourth‑quarter sales of US$63,672 million and net income of US$398 million, alongside a new US$4.00 billion revolving credit facility, a fresh US$5.00 billion share repurchase authorization, and a regular quarterly dividend of US$0.5158 per share. Together with over US$2.08 billion already spent to retire approximately 5.7% of its shares, this combination of earnings growth, expanded liquidity, and stepped-up capital returns highlights management’s...",
                "category": "company",
                "datetime": 1787666723,
                "headline": "What Cardinal Health (CAH)'s New US$5 Billion Buyback and Q4 Results Mean For Shareholders"
              },
              {
                "id": 141363639,
                "url": "https://finnhub.io/api/news?id=b7db85ef45fe1225b5c4ba33e3df77c76fea7b53ff2784fcef5628b38adbdff5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and its peers.",
                "category": "company",
                "datetime": 1787593776,
                "headline": "Winners And Losers Of Q2: Cardinal Health (NYSE:CAH) Vs The Rest Of The Healthcare Providers & Services Stocks"
              },
              {
                "id": 141281569,
                "url": "https://finnhub.io/api/news?id=332992374de53bd9f6bad766edce936b1b27e4f99ea6a4c70d3e55ef4f8bc6e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health earnings and capital return in focus Cardinal Health (CAH) has drawn fresh attention after releasing its fourth quarter and full year 2026 results, paired with a new US$5b share repurchase authorization and a confirmed quarterly dividend. The latest numbers give you an updated view of how the healthcare distributor is converting its large revenue base into profit and cash flow. They also show how management is choosing to return capital to shareholders through buybacks and...",
                "category": "company",
                "datetime": 1787191883,
                "headline": "What Is Drawing Attention To Cardinal Health (CAH) Today?"
              }
            ],
            "raw_source": [
              {
                "id": 142089518,
                "url": "https://finnhub.io/api/news?id=2b34a2a5a93661fb44b03a5ae23beb9474b495656e1ceef30023166f3e89facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.",
                "category": "company",
                "datetime": 1789150860,
                "headline": "CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?"
              },
              {
                "id": 142087142,
                "url": "https://finnhub.io/api/news?id=d6d0c72b86d9e618670b0425256ff71064320995e71838714d702775481e1376",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.",
                "category": "company",
                "datetime": 1789141777,
                "headline": "Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142087143,
                "url": "https://finnhub.io/api/news?id=76d994f26a70f0f9c15f617bc2f51be0a2aaee74fdcd41e930440fc7f064cf70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.",
                "category": "company",
                "datetime": 1789140567,
                "headline": "Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142063302,
                "url": "https://finnhub.io/api/news?id=ad181144a7d06182ba609e0908d03dc6ded85f4ed97764dbd7f7ce1ac0017980",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie's diversified portfolio faces patent headwinds, while Novo Nordisk dominates a faster-growing market, but one trades at a steeper valuation.",
                "category": "company",
                "datetime": 1789062373,
                "headline": "AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142063354,
                "url": "https://finnhub.io/api/news?id=048a492322933b269d7e80caf13a16d0fcc27cc8948d27855f206759fbc84081",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.",
                "category": "company",
                "datetime": 1789057284,
                "headline": "Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142062044,
                "url": "https://finnhub.io/api/news?id=560137700fdb0274b2b3959c029fe5878e28a09596be394126c5f9b6d5d4d425",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1789054203,
                "headline": "Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 142028628,
                "url": "https://finnhub.io/api/news?id=1197e6dcb84032bc3178511ebc59fde338fc46553b3e766a32b3e59929344ec1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson & Johnson (NYSE:JNJ) or Cardinal Health (NYSE:CAH). Mad Money host Jim Cramer said: Well, I’ll tell you… I think it’s always good to look at Lilly as a stock […]",
                "category": "company",
                "datetime": 1788981160,
                "headline": "Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks"
              },
              {
                "id": 142025489,
                "url": "https://finnhub.io/api/news?id=47bba7df8cd0884beabbaf391ec5402e0d0ff0dd0ffcf3aeb8b78535c839408c",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:45 AM EDTCompany ParticipantsDavid Frost - Vice President of...",
                "category": "company",
                "datetime": 1788951426,
                "headline": "Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141956423,
                "url": "https://finnhub.io/api/news?id=3f6f83c743ea38a72b4e2871141f4b5f6bc24bd2000d221a4a264cb9b5aaed21",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.",
                "category": "company",
                "datetime": 1788904802,
                "headline": "Cardinal Health (CAH) Declines More Than Market: Some Information for Investors"
              },
              {
                "id": 141951003,
                "url": "https://finnhub.io/api/news?id=684fd4c8d9debc595b5763345e99d26ea2ae7c3263880deb2d9e34ac89cce05f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.",
                "category": "company",
                "datetime": 1788880020,
                "headline": "Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?"
              },
              {
                "id": 141950716,
                "url": "https://finnhub.io/api/news?id=8483fa41d6072ee44cea77dcbda0a547cebf1d856a602d91d28e799874c7640c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter. The company said Precision Medicine Group would expand two areas it has id",
                "category": "company",
                "datetime": 1788872528,
                "headline": "McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates"
              },
              {
                "id": 141455037,
                "url": "https://finnhub.io/api/news?id=882e78db4092ee8e4a4f8c9153c570608198427b13f54f3413147816ac706bb2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.",
                "category": "company",
                "datetime": 1788547801,
                "headline": "AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141406350,
                "url": "https://finnhub.io/api/news?id=7f06d643160898f1cbdc391a8a9105109c98cd0a5edf1bf978d1a4c97a7e8a62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]",
                "category": "company",
                "datetime": 1788472375,
                "headline": "Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”"
              },
              {
                "id": 141403880,
                "url": "https://finnhub.io/api/news?id=2e84096df15ac30b56cad9794a7c930f96ca0a6d437a48ac470b179160eb83fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.",
                "category": "company",
                "datetime": 1788463320,
                "headline": "Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen"
              },
              {
                "id": 141398251,
                "url": "https://finnhub.io/api/news?id=328a82c3d457909e88b69b893d71448dd5d5c025b99eb4233343050a4eaa9df2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health's generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.",
                "category": "company",
                "datetime": 1788441720,
                "headline": "Is Generics Still a Quiet Profit Engine for Cardinal Health?"
              },
              {
                "id": 141379816,
                "url": "https://finnhub.io/api/news?id=819a041077d747de9514891a7a8d48c4ce98210486c4299517df7996e088af63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Since April 2026, Silchester has had a number of discussions with the Company. Silchester has come to hold serious concerns about the Company's fundamental attitude toward its shareholders. Accordingly, on 2 September 2026, Silchester formally demanded, pursuant to Article 297, Paragraph 1 of the Companies Act, that the Company convene an extraordinary general meeting of shareholders (the \"EGM\") to consider the four proposals summarised below. Silchester has asked that the EGM be held no later t",
                "category": "company",
                "datetime": 1788366960,
                "headline": "Silchester International Investors - Press Release and EGM Demand Letter - Medipal Holdings Corporation (7459:JT)"
              },
              {
                "id": 141376742,
                "url": "https://finnhub.io/api/news?id=6357db02e9beba73d4a317034c225b13d7068feb02e840788847e2ae69d50324",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1788360003,
                "headline": "Is Henry Schein (HSIC) Stock Undervalued Right Now?"
              },
              {
                "id": 141376487,
                "url": "https://finnhub.io/api/news?id=10fcefd3355d598d46e8dca783f9778f4475a83f844c22cffff199cadf2d2ae8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.",
                "category": "company",
                "datetime": 1788356340,
                "headline": "Here's How CVS' Improving Balance Sheet Supports Deleveraging"
              },
              {
                "id": 141377069,
                "url": "https://finnhub.io/api/news?id=d2b0a78c5b2ec6bef921c8a712d6ecb1fbbbb7aa81af14819d5df457b1463590",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CONSHOHOCKEN, Pa., September 02, 2026--Cencora today launched a service to help health systems evaluate, build and scale cell and gene therapy (CGT) programs. Offered through Accelerate Pharmacy Solutions, Cell and Gene Therapy Enablement is designed to help health systems strengthen operational readiness and program execution to reduce barriers to care and expand patient access to advanced therapies.",
                "category": "company",
                "datetime": 1788355800,
                "headline": "Cencora’s Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs"
              },
              {
                "id": 141379924,
                "url": "https://finnhub.io/api/news?id=6afcece2c335857767d8a7dc325db935366d73038876930ff1f2cb2b051c6760",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The healthcare distributor said the incident affected a subset of customers in its oncology and medical-surgical businesses.",
                "category": "company",
                "datetime": 1788349876,
                "headline": "McKesson confirms data theft in cyberattack involving third-party apps"
              },
              {
                "id": 141373305,
                "url": "https://finnhub.io/api/news?id=9938a6ed856998287cea2992d204673e307eddab99bfdaf3d24d3141ba6cb2df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Henry Schein stock performance snapshot Henry Schein (HSIC) stock has drawn investor attention after recent share price moves, with the company reporting positive total returns over the past year and across multi year periods, alongside reported revenue and net income growth. At the latest share price of US$88.52, Henry Schein has given investors a 16.9% share price return over the past 90 days and a 29.4% total shareholder return over the past year. This suggests momentum has been building...",
                "category": "company",
                "datetime": 1788307678,
                "headline": "Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?"
              },
              {
                "id": 141361969,
                "url": "https://finnhub.io/api/news?id=a3d2bd9e2e7a1563d69ec569a40caaa48e51f2d5ae1a31d54ca6f34cc56f0cce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026 FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026 AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is schedul",
                "category": "company",
                "datetime": 1788265800,
                "headline": "FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference"
              },
              {
                "id": 141365811,
                "url": "https://finnhub.io/api/news?id=49d383c4145e42a1a0edc062dc4b916919c3a07f62db12935fc0baad823200ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the “MD Sass Concentrated Value Strategy.” The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led the market, with the Russell 1000 Value increasing by 16.3%, outpacing the S&P 500 (10.2%) and Russell 1000 […]",
                "category": "company",
                "datetime": 1788192071,
                "headline": "Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis"
              },
              {
                "id": 141348564,
                "url": "https://finnhub.io/api/news?id=7009d4f82a8712cebfa86427db9a724d72e0b2b5febcd81764d5d26f56545d3b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.",
                "category": "company",
                "datetime": 1788028861,
                "headline": "AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141361438,
                "url": "https://finnhub.io/api/news?id=940a43f5ddc818d2bd608a743ecdb586ed6fb5e91ade75734e7d1edb77b505aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.",
                "category": "company",
                "datetime": 1788023101,
                "headline": "Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141362279,
                "url": "https://finnhub.io/api/news?id=24b0483fb4d23d2a45eae08e6d6541aacc916e096a9d26974d4a6b6bfd7da4cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.",
                "category": "company",
                "datetime": 1787846340,
                "headline": "How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026"
              },
              {
                "id": 141363637,
                "url": "https://finnhub.io/api/news?id=0009e340eb469a2c2d819aa0627cc009ee92a52abfcd2d125ee0d659256e1f4e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic medical center, Places First Order for LockeT, VTAK’s suture retention device Places its first VIVO 3D Imaging System with a hospital in Germany, one of the largest electrophysiology markets in Europe. FORT MILL, S.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc.’s (NYSE American: VTAK) m",
                "category": "company",
                "datetime": 1787835600,
                "headline": "Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany"
              },
              {
                "id": 141363638,
                "url": "https://finnhub.io/api/news?id=381f009c81a44d952d5b643ae88cfde27e54b5e058c2e9ad1f0d9b32734760d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In August 2026, Cardinal Health reported fourth‑quarter sales of US$63,672 million and net income of US$398 million, alongside a new US$4.00 billion revolving credit facility, a fresh US$5.00 billion share repurchase authorization, and a regular quarterly dividend of US$0.5158 per share. Together with over US$2.08 billion already spent to retire approximately 5.7% of its shares, this combination of earnings growth, expanded liquidity, and stepped-up capital returns highlights management’s...",
                "category": "company",
                "datetime": 1787666723,
                "headline": "What Cardinal Health (CAH)'s New US$5 Billion Buyback and Q4 Results Mean For Shareholders"
              },
              {
                "id": 141363502,
                "url": "https://finnhub.io/api/news?id=0a0c83d8ecf1ecf11da38b06678ec3d7da86b5717bddd2b768f42a4af66175b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.",
                "category": "company",
                "datetime": 1787654564,
                "headline": "2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down"
              },
              {
                "id": 141362494,
                "url": "https://finnhub.io/api/news?id=813bbe30273839d5c9e39751e4840e5380adf79983ce68785f5bc9d92a450f8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate"
              },
              {
                "id": 141362493,
                "url": "https://finnhub.io/api/news?id=a26caf7ebd42adc41c28417195d15ca548d9f7918e53a2033fe7bbaeb5ef1826",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?"
              },
              {
                "id": 141363645,
                "url": "https://finnhub.io/api/news?id=264a19181593f4971980165e459392bd4e0b8e274225be280b6620bad4285ede",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH enters fiscal 2027 with strong specialty growth, but IRA pricing changes, GMPD challenges and heavy CapEx pose risks.",
                "category": "company",
                "datetime": 1787600820,
                "headline": "Reasons to Retain Cardinal Health Stock in Your Portfolio for Now"
              },
              {
                "id": 141363639,
                "url": "https://finnhub.io/api/news?id=b7db85ef45fe1225b5c4ba33e3df77c76fea7b53ff2784fcef5628b38adbdff5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and its peers.",
                "category": "company",
                "datetime": 1787593776,
                "headline": "Winners And Losers Of Q2: Cardinal Health (NYSE:CAH) Vs The Rest Of The Healthcare Providers & Services Stocks"
              },
              {
                "id": 141302889,
                "url": "https://finnhub.io/api/news?id=416bab4b1c0101a3af5b6372944a639d163e1a4ca056c79bfe84910c7f68b6e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Mary C. Scherer reduced her direct equity but retains 2,811 shares after the stock delivered a 58% return over the past year.",
                "category": "company",
                "datetime": 1787489912,
                "headline": "What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer"
              },
              {
                "id": 141302890,
                "url": "https://finnhub.io/api/news?id=ff6c5bc5e1602794a100e7f9ac2028e3ce773d8e891979bf3aa2f2b45090397a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Alt divested part of his direct equity stake after the stock surged 57% over the past year, retaining 20,495 shares worth $4.82 million.",
                "category": "company",
                "datetime": 1787489479,
                "headline": "Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know"
              },
              {
                "id": 141302891,
                "url": "https://finnhub.io/api/news?id=97960969121b0a2e7900f606decbb1c933ac1e1698d04ddb351595c45c228b7a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "This insider sale cut an equity stake following a strong 57% one-year stock run, leaving $4.2 million in direct holdings.",
                "category": "company",
                "datetime": 1787488920,
                "headline": "Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know"
              },
              {
                "id": 141302893,
                "url": "https://finnhub.io/api/news?id=b68995767b73314e066ba16ebd0a5e5a40067120b091ad131376f9d7621e8b56",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Weitzman's equity reduction follows a 57% one-year stock price surge, leaving her with $18.3 million in direct holdings.",
                "category": "company",
                "datetime": 1787488459,
                "headline": "Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened"
              },
              {
                "id": 141302894,
                "url": "https://finnhub.io/api/news?id=74d086da412e2f40effa473609db11e342a4c02990853c02087d42b7ab2afb5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Michelle Greene reduced her direct equity stake following strong stock appreciation, retaining 10,330 shares worth $2.43 million.",
                "category": "company",
                "datetime": 1787488071,
                "headline": "The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors"
              },
              {
                "id": 141302895,
                "url": "https://finnhub.io/api/news?id=b3c419f800f6985e46c2edeccfe50c3194e81705fe3b88954694b93594b8c862",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Jessica Mayer holds 33,076 shares valued at $7.77 million.",
                "category": "company",
                "datetime": 1787487298,
                "headline": "Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know"
              },
              {
                "id": 141302896,
                "url": "https://finnhub.io/api/news?id=886093364dc83c06f6d58fa489627171dda909f2ce2ded5a91ad90ae33d05b8c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Hollar divested 125,000 shares across two trading sessions, reducing his direct holdings following a 58% one-year stock surge.",
                "category": "company",
                "datetime": 1787485488,
                "headline": "Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know"
              },
              {
                "id": 141281561,
                "url": "https://finnhub.io/api/news?id=7a9934a73093f4678229a178aa7bb825d5e23cc05353b69220c25cff9f855440",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CEO Jason Hollar leads a wave of insider selling that saw top executives liquidate nearly $60 million worth of company stock.",
                "category": "company",
                "datetime": 1787359440,
                "headline": "Cardinal Health CEO Sells $29 Million in Stock After Earnings Send Shares to Record"
              },
              {
                "id": 141281569,
                "url": "https://finnhub.io/api/news?id=332992374de53bd9f6bad766edce936b1b27e4f99ea6a4c70d3e55ef4f8bc6e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health earnings and capital return in focus Cardinal Health (CAH) has drawn fresh attention after releasing its fourth quarter and full year 2026 results, paired with a new US$5b share repurchase authorization and a confirmed quarterly dividend. The latest numbers give you an updated view of how the healthcare distributor is converting its large revenue base into profit and cash flow. They also show how management is choosing to return capital to shareholders through buybacks and...",
                "category": "company",
                "datetime": 1787191883,
                "headline": "What Is Drawing Attention To Cardinal Health (CAH) Today?"
              },
              {
                "id": 141257357,
                "url": "https://finnhub.io/api/news?id=bb7bbbae3a015fc8491aace84d7c755899956d9398b88bd5dfe4dbd9e355f6f1",
                "image": "",
                "source": "Fintel",
                "related": "CAH",
                "summary": "",
                "category": "company",
                "datetime": 1787177498,
                "headline": "RBC Capital Initiates Coverage of Cardinal Health (CAH) with Outperform Recommendation"
              },
              {
                "id": 141281562,
                "url": "https://finnhub.io/api/news?id=9bec7570f1e53c9fc78fbb7e90d04b77446549aa9fbb3b3787dc5c736db5d10e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On August 11, Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results that on the surface look almost too good to be true. Non-GAAP diluted EPS jumped 40% year over year to $2.91, and full-year adjusted free cash flow hit $5 billion. But a large piece of that quarterly jump came from a one-time tariff refund, […]",
                "category": "company",
                "datetime": 1787161820,
                "headline": "Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story"
              },
              {
                "id": 141281563,
                "url": "https://finnhub.io/api/news?id=f198ed3b0fb67fa0c414360083a0eb1dddb2ec041ab74231173ee46546a45c11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health's (CAH) vertical integration of \"higher-growth and higher-margin services\" will comp",
                "category": "company",
                "datetime": 1787155323,
                "headline": "Cardinal Health's Integration of Higher-Margin Services Will Drive Outperformance, RBC Says"
              },
              {
                "id": 141255098,
                "url": "https://finnhub.io/api/news?id=407cd590acc44067e69ec21c3b5d573dbff31e348a254be4edac3e8cfcac88f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1787150302,
                "headline": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141259500,
                "url": "https://finnhub.io/api/news?id=cb4ae7c43fea7b23d204dbd5f2a4b5ea60ff0d71b6a43a109dfaf6de68fb5c7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Markets turned south again Wednesday as surging yields and geopolitical fears rattled investors, but Wall Street analysts spotted opportunity and danger in names like Baidu, Klarna, Honeywell Aerospace, and Dollar Tree that traders need to see before the open.",
                "category": "company",
                "datetime": 1787144196,
                "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: Baidu, Ciena, CME Group, Dollar Tree, Dominion, Fabrinet, Honeywell Aerospace, Klarna, Pershing Square, and More"
              },
              {
                "id": 141253695,
                "url": "https://finnhub.io/api/news?id=3c3066b7a556a34c1a084c681d5941596afec66a3fdaf375963338e9d1e32f6d",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "RBC Capital  analyst Ryan Halsted   initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.",
                "category": "company",
                "datetime": 1787132694,
                "headline": "RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276"
              },
              {
                "id": 141253214,
                "url": "https://finnhub.io/api/news?id=55b2612597751aff2579b02d0a94b174d997e251973f5cbbcbbb21cc957e62b9",
                "image": "",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "",
                "category": "company",
                "datetime": 1787129746,
                "headline": "Cardinal Health: Precision Medicine Drives A Sustained Revenue Growth Path"
              },
              {
                "id": 141279877,
                "url": "https://finnhub.io/api/news?id=c47505c3dc9586b3a6348210ab896b422c8c06eda61b4c18fa117bc974b4f9e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "OPK raises $125 million against mazdutide royalties, gaining non-dilutive capital while retaining longer-term royalty upside.",
                "category": "company",
                "datetime": 1787077380,
                "headline": "OPKO Health Secures $125 Million Financing Against Mazdutide Royalties"
              },
              {
                "id": 141281564,
                "url": "https://finnhub.io/api/news?id=f6f0cb7498e1d33d53716ba1b2fe269651b58bc632951f6ab547d308849691eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GLP-1 tailwinds and specialty strength drove pharma profit up 21% in Q4.",
                "category": "company",
                "datetime": 1787067813,
                "headline": "Cardinal Health (CAH) Q4 2026 Earnings Call Transcript"
              },
              {
                "id": 141281565,
                "url": "https://finnhub.io/api/news?id=aa7893dba0b7ba30e6775070e552e7c107e3b8b80c13bda3b71dc4b7e59ba2ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.",
                "category": "company",
                "datetime": 1787055182,
                "headline": "Baxter’s interim CFO leaves for Cardinal Health"
              },
              {
                "id": 141281566,
                "url": "https://finnhub.io/api/news?id=8059c2d2ad511cac4cd33d5903fdb21dd7fbe90810769d4eacc4c628e23c26e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health’s second quarter results reflected strong profit growth, despite revenue falling short of Wall Street’s expectations. Management credited broad-based demand in its Pharmaceutical and Specialty Solutions segment, stable operating margins, and continued progress on its improvement plan in the Global Medical Products and Distribution unit as key performance drivers. CFO Aaron Alt called out “strong demand, strong execution, strong profit,” highlighting the company’s ability to deliv",
                "category": "company",
                "datetime": 1787043453,
                "headline": "5 Revealing Analyst Questions From Cardinal Health’s Q2 Earnings Call"
              },
              {
                "id": 141281572,
                "url": "https://finnhub.io/api/news?id=9cc59241381a967f196ccd02f616c9c312113bf0d32eb77878540773004d7acd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.",
                "category": "company",
                "datetime": 1786988703,
                "headline": "3 Reasons Growth Investors Will Love Cardinal (CAH)"
              },
              {
                "id": 141237777,
                "url": "https://finnhub.io/api/news?id=7c05a7bfce72694815f544e874b23f60dca0c5bfcc88c83bdc9eab942fd3c0e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
                "category": "company",
                "datetime": 1786841580,
                "headline": "1 S&P 500 Stock Worth Investigating and 2 We Turn Down"
              },
              {
                "id": 141223241,
                "url": "https://finnhub.io/api/news?id=33a2434b268e9c2c0fa89571638f2150a7ee2e9c0b89bccb945d9e3a0e34de88",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.",
                "category": "company",
                "datetime": 1786736789,
                "headline": "AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141237771,
                "url": "https://finnhub.io/api/news?id=e17fa0d13076a4a8bd279c74b3e414d9f3501a2dc67174b4a2bce7c8b3aa49ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Jason Hollar, Cardinal Health (CAH) CEO joins Yahoo Finance Executive Editor Brian Sozzi to detail how M&A strategy, specialty pharma growth, and drug volume dynamics are driving profits.",
                "category": "company",
                "datetime": 1786732188,
                "headline": "Cardinal Health CEO details M&A strategy and growth"
              },
              {
                "id": 141237778,
                "url": "https://finnhub.io/api/news?id=367a84c2f8076f5a8bad9804ededf729b3319df5dfda2f5bb74e17f5d37735d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.",
                "category": "company",
                "datetime": 1786721760,
                "headline": "Reasons to Hold Hinge Health Stock in Your Portfolio for Now"
              },
              {
                "id": 141237779,
                "url": "https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.",
                "category": "company",
                "datetime": 1786721700,
                "headline": "SOLV Plans Health Information Systems Business Spinoff to Drive Growth"
              },
              {
                "id": 141237780,
                "url": "https://finnhub.io/api/news?id=bb5d54af2d975e1d0735d6f3c1a639d678139f27cb2646fee50303085609a3dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health advances its $20 billion technology push with AI tools, Health100 and automation aimed at simplifying care and improving engagement.",
                "category": "company",
                "datetime": 1786718340,
                "headline": "How CVS Is Building on Its Consumer-Health Care Technology Push"
              },
              {
                "id": 141237775,
                "url": "https://finnhub.io/api/news?id=a4bceb6094e64669174ffe675842af9d12ccc8f13e47a1a88b434206e3cc4192",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare distributor and services company Cardinal Health (NYSE:CAH) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 5.8% year on year to $63.67 billion. Its non-GAAP profit of $2.60 per share was 7.4% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786718220,
                "headline": "CAH Q2 CY2026 Deep Dive: Specialty Momentum, Strategic Investments, and Guidance Above Street Expectations"
              },
              {
                "id": 141237781,
                "url": "https://finnhub.io/api/news?id=f9e26e1d7842ce5bcadb6ab5942b24de626a56dfb0bf3390b7003be284bc425f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here is how BioMarin Pharmaceutical (BMRN) and Cardinal Health (CAH) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1786714802,
                "headline": "Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 141237782,
                "url": "https://finnhub.io/api/news?id=bfbc65f21c26c1d88a19ea9c089289af8c87bd78d8db8c3f88fb891bca7fb305",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Monolithic Power Systems is benefiting from surging AI demand, while Las Vegas Sands faces earnings pressure and a prolonged downtrend.",
                "category": "company",
                "datetime": 1786699680,
                "headline": "Monolithic Power Systems and Las Vegas Sands have been highlighted as Zacks Bull and Bear of the Day"
              },
              {
                "id": 141215083,
                "url": "https://finnhub.io/api/news?id=598a7584576f7c61713e7621fce46c4faa8fbe12fa1ed4b413f52bec8de4fa49",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Keurig Dr Pepper has recently reported second-quarter 2026 results showing sales of US$7.31 billion and net income of US$142 million, while rolling out a lime-led reformulation of 7UP and partnering with Portillo’s on limited-time Dr Pepper shakes in the U.S. Alongside these product moves, the company has added Cardinal Health CFO Aaron Alt to its board as it works through a planned split into separate beverage and coffee businesses. With Aaron Alt joining the board during Keurig Dr Pepper’s...",
                "category": "company",
                "datetime": 1786684378,
                "headline": "Did New 7UP Formula, Dr Pepper Shakes and Board Addition Just Shift Keurig Dr Pepper's (KDP) Investment Narrative?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 64,
            "discarded_article_count": 51
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.7,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 3,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 3,
            "vcp_reason": "波幅收縮(14.6%→6.7%)；量縮(v10/v30=0.81)；跌縮量(近10日4日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 1725350,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1395800,
              "avg_vol_20": 1532380,
              "avg_vol_30": 1725350,
              "range_pct_10": 0.06727202680342641,
              "range_pct_20": 0.0921260138923982,
              "range_pct_30": 0.1457560154428947,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8089952763207465,
              "dist_to_20d_high": 0.05904761759587697,
              "down_shrink_days": 4,
              "breakout_level_20d": 249.28999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4615385965307394
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.1154025614783407,
              "turnoverUsdM": 260.748023116,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CAH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 224.6458,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.2,
            "take_profit_price": 246.2985,
            "target_multiplier": 1.9,
            "technical_strength": 1.68,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.230805122956681,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 4.9621,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.12
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -29.59
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0578
    },
    "kdj": {
      "d": 52.52,
      "j": -1.15,
      "k": 34.63,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 51.6
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 4546900,
      "recentSlope": -74700,
      "previousSlope": -17620
    },
    "rsi": 56.19,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 249.29,
      "position": "SAR喺價上",
      "distancePct": 6.28,
      "previousTrend": "上升"
    },
    "ma50": 234.2584,
    "macd": {
      "macd": 1.64392080054958,
      "trend": "中性偏多",
      "signal": 2.043058007716115,
      "histogram": -0.3991372071665351
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 237.1427,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.77,
      "score": 2,
      "avgVolume": 1445705,
      "currentVolume": 1111600
    },
    "derived": {
      "ma20": 237.1665,
      "ma50": 234.2584,
      "prevClose": 236.02,
      "avgVolume10": 1403600,
      "avgVolume20": 1445705,
      "changePercent": -0.61,
      "avgVolumeForScore": 1445705
    },
    "ma_cross": {
      "ma20": 237.1665,
      "ma50": 234.2584,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 237,
      "prevMa50": 234.3214,
      "spreadPct": 1.24,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 226.9117,
      "upper": 247.4213,
      "position": "中間"
    },
    "rsi_short": 18.18,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.77
    }
  }
}

{
  "close": 234.57,
  "volume": 1111600,
  "changePercent": -0.61
}